WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004035103) FUNCTIONALISATION OF STENTS WITH LIPASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/035103    International Application No.:    PCT/EP2003/050680
Publication Date: 29.04.2004 International Filing Date: 02.10.2003
Chapter 2 Demand Filed:    19.03.2004    
IPC:
A61L 31/16 (2006.01)
Applicants: EUROPEAN COMMUNITY, represented by THE EUROPEAN COMMISSION [--/BE]; B-1049 Brussels (BE) (For All Designated States Except US).
MCSWEENEY, Finbare, Alain [IE/BE]; (BE) (For US Only).
ROSSI, François [FR/IT]; (IT) (For US Only).
GRIBALDO, Laura [IT/IT]; (IT) (For US Only)
Inventors: MCSWEENEY, Finbare, Alain; (BE).
ROSSI, François; (IT).
GRIBALDO, Laura; (IT)
Agent: SCHMITT, Armand; Office Ernest T. Freylinger S.A., B.P. 48, L-8001 Strassen (LU)
Priority Data:
02292525.9 14.10.2002 EP
Title (EN) FUNCTIONALISATION OF STENTS WITH LIPASES
(FR) FONCTIONALISATION D'ENDOPROTHESES AVEC DES LIPASES
Abstract: front page image
(EN)The invention relates to intravascular stents comprising in its inner surface an enzyme capable of catabolizing cholesterol and lipids, such as lipase, or cells that have been genetically modified to produce said enzyme, and to their use in the frame of the treatment or prevention of obstructive artheriosclerotic lesions in the coronary and peripheral blood vessels, or prevention of restenosis in intra coronaric stents.
(FR)L'invention concerne des endoprothèses intravasculaires comportant sur leur surface interne une enzyme pouvant cataboliser le cholestérol et des lipides, telle qu'une lipase, ou des cellules modifiées génétiquement afin de produire cette enzyme, et leur utilisation dans le cadre du traitement ou de la prévention de lésions artériosclérotiques obstructives dans les vaisseaux sanguins périphériques ou coronaires, ou de resténose dans des endoprothèses intracoronaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)